FDA Inspection
Guardian Drug Co. Inc.Guardian Drug Co. Inc. – FDA Inspection, Mar 2, 2012
Record Details
This FDA Inspection record concerns Guardian Drug Co. Inc., with an inspection on March 2, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Guardian Drug Co. Inc.
- Inspection Date
- March 2, 2012
- Product Type
- Drugs
View Company Profile
ID · a0f19cb7-a1a6-45e7-acb7-6c4a952c9519
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 770146
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Guardian Drug Co. Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| January 16, 2026 | Not classified | New Jersey District Office | |
| November 7, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 17, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 6, 2016 | Not classified | New Jersey District Office |
Other documents for Guardian Drug Co. Inc.
- FDA Inspection 1304382 - 2026-01-16
- FDA Inspection 1231141 - 2024-11-07
- FDA Inspection 1162476 - 2022-02-17
- FDA Inspection 1030766 - 2017-11-06
- FDA Inspection 996009 - 2016-12-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.